These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19022404)

  • 1. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
    Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
    Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment.
    Shirinsky IV; Zheltova OI; Solovyova NY; Kozlov VA; Shirinsky VS
    Scand J Rheumatol; 2009; 38(1):23-7. PubMed ID: 18830905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro.
    Henrich D; Seebach C; Wilhelm K; Marzi I
    J Surg Res; 2007 Sep; 142(1):13-9. PubMed ID: 17716606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Yokota K; Miyazaki T; Hirano M; Akiyama Y; Mimura T
    J Rheumatol; 2006 Mar; 33(3):463-71. PubMed ID: 16511915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients.
    Sternberg Z; Chadha K; Lieberman A; Hojnacki D; Drake A; Zamboni P; Rocco P; Grazioli E; Weinstock-Guttman B; Munschauer F
    J Neuroimmunol; 2008 Dec; 205(1-2):142-7. PubMed ID: 18926575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.
    Waehre T; Yndestad A; Smith C; Haug T; Tunheim SH; Gullestad L; Frøland SS; Semb AG; Aukrust P; Damås JK
    Circulation; 2004 Apr; 109(16):1966-72. PubMed ID: 15051633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
    Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells.
    Bessler H; Salman H; Bergman M; Straussberg R; Djaldetti M
    Clin Immunol; 2005 Oct; 117(1):73-7. PubMed ID: 16051523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-beta modifies the peripheral blood cell cytokine secretion in patients with multiple sclerosis.
    Mirandola SR; Hallal DE; Farias AS; Oliveira EC; Brandão CO; Ruocco HH; Damasceno BP; Santos LM
    Int Immunopharmacol; 2009 Jul; 9(7-8):824-30. PubMed ID: 19289181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis.
    Sellner J; Greeve I; Findling O; Kamm CP; Minten C; Engelhardt B; Grandgirard D; Leib SL; Mattle HP
    Neurochem Int; 2008 Jul; 53(1-2):17-21. PubMed ID: 18524417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
    Vanderlocht J; Hendriks JJ; Venken K; Stinissen P; Hellings N
    J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin induces interleukin-18 production in human peripheral blood mononuclear cells.
    Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Nishibori M
    Clin Immunol; 2005 Sep; 116(3):211-6. PubMed ID: 15936988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
    Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S
    Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC.
    Bergman M; Salman H; Djaldetti M; Bessler H
    Vascul Pharmacol; 2011; 54(3-6):88-92. PubMed ID: 21440087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
    Kagami S; Kanari H; Suto A; Fujiwara M; Ikeda K; Hirose K; Watanabe N; Iwamoto I; Nakajima H
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():61-6. PubMed ID: 18504409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
    Turner NA; Midgley L; O'Regan DJ; Porter KE
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
    Zhang X; Tao Y; Troiani L; Markovic-Plese S
    J Immunol; 2011 Sep; 187(6):3431-7. PubMed ID: 21856936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin D and β-sitosterol on immune function of macrophages.
    Alappat L; Valerio M; Awad AB
    Int Immunopharmacol; 2010 Nov; 10(11):1390-6. PubMed ID: 20728596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of simvastatin on cytokines secretion from mononuclear cells from critically ill patients with acute kidney injury.
    Ferrari GL; Quinto BM; Queiroz KC; Iizuka IJ; Monte JC; Dalboni MA; Durão MS; Cendoroglo Neto M; dos Santos OF; Batista MC
    Cytokine; 2011 May; 54(2):144-8. PubMed ID: 21367616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
    Kieseier BC; Archelos JJ; Hartung HP
    Arch Neurol; 2004 Jun; 61(6):929-32. PubMed ID: 15210533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.